Massachusetts Citizens for Life Board Member and Director of APRScience.org, Paul DeBeasi, recently represented the organization as a speaker at the Heartbeat International (HBI) Annual Conference—one of the largest pro-life gatherings in the world.

A new report by the Ethics and Public Policy Center has raised significant concerns about the safety of the abortion pill, mifepristone, showing that nearly one in ten women experience serious adverse events after taking the drug.

Paul DeBeasi, Director of APRScience.org and executive board member of Massachusetts Citizens for Life, will lead a key workshop at the 2025 Heartbeat Conference in Birmingham, Alabama.

WALPOLE, MA - Massachusetts Citizens for Life proudly announces the launch of a new resource from its affiliate project, APRScience. Available at aprscience.org/myths, this page addresses widespread misinformation about Abortion Pill Reversal (APR). It features annotated video transcripts from renowned obstetrician and gynecologist Dr. Christina Francis, CEO of the American Association of Pro-Life Obstetricians and Gynecologists.

On Friday, March 1, 2024, CVS and Walgreens announced that they will begin selling the abortion pills, mifepristone and misoprostol, in Massachusetts. The chains recently received certification to dispense the drugs in a small group of states, a process they initiated after the Food and Drug Administration (FDA) approved new regulations last year allowing brick and mortar retailers to offer chemical abortion.

In a highly anticipated announcement, The United States Supreme Court said today that it will hear oral arguments next spring related to chemical abortion, specifically about safety restrictions that should or should not be in place.

We are excited to let you know about upcoming webinars in the next few weeks. Additionally, we have essential information to share about a key vote happening next week.